UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors

European journal of heart failure, 2017-11, Vol.19 (11), p.1390-1400

2017

Volltextzugriff (PDF)

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)

Circulation (New York, N.Y.), 2017-05, Vol.135 (20), p.1911-1921

2017

Volltextzugriff (PDF)

External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial

Diabetes, obesity & metabolism, 2023-01, Vol.25 (1), p.229-237

2023

Volltextzugriff (PDF)

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial

Diabetes, obesity & metabolism, 2017-05, Vol.19 (5), p.664-671

2017

Volltextzugriff (PDF)

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Diabetes care, 2018-12, Vol.41 (12), p.2603-2609

2018

Volltextzugriff (PDF)

Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial

The American heart journal, 2016-05, Vol.175, p.18-27

2016

Volltextzugriff (PDF)

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

The Lancet (British edition), 2015-05, Vol.385 (9982), p.2067-2076

2015

Volltextzugriff (PDF)

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

The New England journal of medicine, 2013-10, Vol.369 (14), p.1327-1335

2013

Volltextzugriff (PDF)

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

The New England journal of medicine, 2015-02, Vol.372 (8), p.735-746

2015

Volltextzugriff (PDF)

Bivalirudin Started during Emergency Transport for Primary PCI

The New England journal of medicine, 2013-12, Vol.369 (23), p.2207-2217

2013

Volltextzugriff (PDF)

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial

Diabetes care, 2016-07, Vol.39 (7), p.1267-1273

2016

Volltextzugriff (PDF)

Tappas: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS11081-TPS11081

2017

Volltextzugriff (PDF)

TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS11590-TPS11590

2018

Volltextzugriff (PDF)

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

Hypertension (Dallas, Tex. 1979), 2016-09, Vol.68 (3), p.606-613

2016

Volltextzugriff (PDF)

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trial

Diabetes, obesity & metabolism, 2017-05, Vol.19 (5), p.664-671

2017

Volltextzugriff (PDF)

Abstract 17295: Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Ischemic Cardiac Outcomes and Hospitalizations According to Prior Macrovascular Disease Status in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome from the EXAMINE trial

The American heart journal, 2015

2015

Volltextzugriff (PDF)

VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS6637-TPS6637

2012

Volltextzugriff (PDF)

The exact analysis of contingency tables in medical research

Statistical methods in medical research, 1994, Vol.3 (2), p.135-156

Mehta, Cyrus R

1994

Volltextzugriff (PDF)

Sequential comparison of two exponential distributions with censored survival data

Biometrika, 1981-12, Vol.68 (3), p.669-675

Mehta, Cyrus R.

1981

Volltextzugriff (PDF)

Constructing exact significance tests with restricted randomization rules

Biometrika, 1988-06, Vol.75 (2), p.295-302

1988

Volltextzugriff (PDF)

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung. Low response rate in a cooperative group study

Cancer, 1979-01, Vol.44 (3), p.864-868

1979

Volltextzugriff (PDF)

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung.Low response rate in a cooperative group study

Cancer, 1979-09, Vol.44 (3), p.864-868

1979

Volltextzugriff (PDF)

Sequential analysis of comparative clinical trials

Biometrika, 1979-04, Vol.66 (1), p.97-103

1979

Volltextzugriff (PDF)

Cancer Mortality Among Beekeepers

Journal of occupational medicine, 1979-12, Vol.21 (12), p.811-813

1979

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(18)
Female
(13)
Male
(13)
Diabetes
(10)
Middle Aged
(10)
Aged
(9)
Double-Blind Method
(9)
Heart Failure
(9)
Cardiovascular System & Cardiology
(8)
Cardiac & Cardiovascular Systems
(7)
Clinical Trials
(7)
Diabetes Mellitus
(7)
Myocardial Infarction
(7)
Uracil - Analogs & Derivatives
(7)
Acute Coronary Syndromes
(6)
General & Internal Medicine
(6)
Hypoglycemic Agents - Therapeutic Use
(6)
Medicine, General & Internal
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)

External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

Bivalirudin Started during Emergency Transport for Primary PCI

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial

Tappas: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS)

TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trial

Abstract 17295: Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial

Ischemic Cardiac Outcomes and Hospitalizations According to Prior Macrovascular Disease Status in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome from the EXAMINE trial

VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia

The exact analysis of contingency tables in medical research

Sequential comparison of two exponential distributions with censored survival data

Constructing exact significance tests with restricted randomization rules

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung. Low response rate in a cooperative group study

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung.Low response rate in a cooperative group study

Sequential analysis of comparative clinical trials

Cancer Mortality Among Beekeepers

Aktive Filter

Suchergebnisse filtern